Statement of Cash FlowsIndirect Method

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:

		Dec. 31, 20Y3		Dec. 31, 20Y2
Assets
Cash		$241,460		$226,680
Accounts receivable (net)		87,470		81,410
Inventories		246,920		241,060
Investments		0		93,390
Land		126,650		0
Equipment		272,440		213,110
Accumulated depreciationequipment		(63,780)		(57,470)
	Total assets	$911,160		$798,180
Liabilities and Stockholders' Equity
Accounts payable (merchandise creditors)		$164,920		$157,240
Accrued expenses payable (operating expenses)		16,400		20,750
Dividends payable		9,110		7,180
Common stock, $10 par		49,200		39,110
Paid-in capital: Excess of issue price over par-common stock		184,970		108,550
Retained earnings		486,560		465,350
	Total liabilities and stockholders equity	$911,160		$798,180

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

The investments were sold for $109,270 cash.

Equipment and land were acquired for cash.

There were no disposals of equipment during the year.

The common stock was issued for cash.

There was a $58,720 credit to Retained Earnings for net income.

There was a $37,510 debit to Retained Earnings for cash dividends declared.

Required:

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

Livers Inc.
Statement of Cash Flows
For the Year Ended December 31, 20Y3
Cash flows from operating activities:
	$
Adjustments to reconcile net income to net cash flow from operating activities:
Changes in current operating assets and liabilities:
Net cash flow from operating activities		$
Cash flows from investing activities:
	$
Net cash flow used for investing activities
Cash flows from financing activities:
	$
Net cash flow from financing activities
		$
Cash at the beginning of the year
Cash at the end of the year		$